Controlling drug-to-antibody ratio and scalable reactors are key to reliable antibody-drug conjugate manufacturing success.

This is read by an automated voice. Please report any issues or inconsistencies here. At the dawn of 2026, social media influencers at home and abroad proclaimed it the year of the “analog lifestyle,” ...

The AD4081 20-bit, 20 MSPS successive approximation register (SAR) analog-to-digital converters (ADC) from Analog Devices are designed for high-performance data acquisition systems. They are in stock ...

Abstract: The noise-shaping (NS) successive-approximation register (SAR) has become a dominant emerging ADC architecture in a short time. Combining the benefits of SAR and noise shaping, NS-SAR ADCs ...

Genmab has shed another antibody-drug conjugate from its April 2024 acquisition of ProfoundBio. The Danish pharma has dropped development of GEN1160, a company spokesperson confirmed to Fierce Biotech ...

Tubulis’ next-generation antibody-drug conjugate (ADC) has been tied to an overall response rate (ORR) of 59% as the German biotech tastes its first clinical success. The Munich-based company is ...

AstraZeneca and Daiichi Sankyo’s Datroway has become the first cancer drug to show an overall survival benefit against chemotherapy for certain patients with a particularly aggressive form of breast ...

Explore how digital feedback controllers manage motors, pressure, temperature, and more, and learn why ADC and DAC performance are crucial when designing robust embedded systems. How to define the ...